BioCentury | Nov 14, 2020
Product Development

ASH 2020 snapshot: efficacy data in hot emerging areas

...trial design for AK117.Arch Oncology Inc., ImmuneOncia Therapeutics Inc., Invenra Inc....
BioCentury | Nov 11, 2020
Deals

Previewing CD47 efficacy data at SITC & ASH: Data Byte

...trial design for AK117.Arch Oncology Inc., ImmuneOncia Therapeutics Inc., Invenra Inc....
BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...He was VP of medical affairs and clinical research at Omeros Corp. (NASDAQ:OMER). Immuno-oncology company Invenra Inc....
BioCentury | Jul 23, 2018
Company News

Management tracks: CStone, BMS

...Genome Inc. (South San Francisco, Calif.) hired Anupama Hoey as CBO. She was CBO at Invenra Inc....
BioCentury | May 4, 2018
Company News

Exelixis, Invenra partner for multispecific antibodies

...NASDAQ:EXEL) and Invenra Inc. (Madison, Wis.) partnered to identify and develop multispecific antibodies for cancer using Invenra's...
...Madison, Wis.) partnered to identify and develop multispecific antibodies for cancer using Invenra's B-Body platform. Invenra...
...tiered royalties. Invenra Inc., Madison, Wis. Exelixis Inc. (NASDAQ:EXEL), South San Francisco, Calif. Business: Cancer Allison Johnson Exelixis Inc. Invenra Inc....
BioCentury | Aug 18, 2017
Company News

Invenra, Merck partner to discover antibodies

...In July, Invenra Inc. (Madison, Wis.) and Merck & Co. Inc. (NYSE:MRK) partnered to discover antibodies against...
...Merck & Co. Inc. (NYSE:MRK) partnered to discover antibodies against an undisclosed target from Merck. Invenra's...
...screening using mAbSeq for bispecific combinations. Invenra declined to provide additional details regarding the deal. Invenra...
BioCentury | Mar 3, 2017
Company News

Invenra, QIMR Berghofer deal

...mAbSeq technology. Invenra deferred questions to QIMR, which did not respond in time for publication. Invenra Inc....
...Wis. QIMR Berghofer Medical Research Institute , Brisbane, Australia Business: Cancer, Antibodies, High throughput screening Alex Himes Invenra Inc. QIMR...
BioCentury | Aug 3, 2015
Company News

Invenra, Oxford BioTherapeutics deal

...human mAbs against an undisclosed cancer target that Oxford identified using its OGAP discovery platform. Invenra...
...and will be responsible for development. Invenra is eligible to receive milestone payments and royalties. Invenra Inc....
Items per page:
1 - 8 of 8
BioCentury | Nov 14, 2020
Product Development

ASH 2020 snapshot: efficacy data in hot emerging areas

...trial design for AK117.Arch Oncology Inc., ImmuneOncia Therapeutics Inc., Invenra Inc....
BioCentury | Nov 11, 2020
Deals

Previewing CD47 efficacy data at SITC & ASH: Data Byte

...trial design for AK117.Arch Oncology Inc., ImmuneOncia Therapeutics Inc., Invenra Inc....
BioCentury | Sep 10, 2018
Company News

Management tracks: PolarityTE, Medivir

...He was VP of medical affairs and clinical research at Omeros Corp. (NASDAQ:OMER). Immuno-oncology company Invenra Inc....
BioCentury | Jul 23, 2018
Company News

Management tracks: CStone, BMS

...Genome Inc. (South San Francisco, Calif.) hired Anupama Hoey as CBO. She was CBO at Invenra Inc....
BioCentury | May 4, 2018
Company News

Exelixis, Invenra partner for multispecific antibodies

...NASDAQ:EXEL) and Invenra Inc. (Madison, Wis.) partnered to identify and develop multispecific antibodies for cancer using Invenra's...
...Madison, Wis.) partnered to identify and develop multispecific antibodies for cancer using Invenra's B-Body platform. Invenra...
...tiered royalties. Invenra Inc., Madison, Wis. Exelixis Inc. (NASDAQ:EXEL), South San Francisco, Calif. Business: Cancer Allison Johnson Exelixis Inc. Invenra Inc....
BioCentury | Aug 18, 2017
Company News

Invenra, Merck partner to discover antibodies

...In July, Invenra Inc. (Madison, Wis.) and Merck & Co. Inc. (NYSE:MRK) partnered to discover antibodies against...
...Merck & Co. Inc. (NYSE:MRK) partnered to discover antibodies against an undisclosed target from Merck. Invenra's...
...screening using mAbSeq for bispecific combinations. Invenra declined to provide additional details regarding the deal. Invenra...
BioCentury | Mar 3, 2017
Company News

Invenra, QIMR Berghofer deal

...mAbSeq technology. Invenra deferred questions to QIMR, which did not respond in time for publication. Invenra Inc....
...Wis. QIMR Berghofer Medical Research Institute , Brisbane, Australia Business: Cancer, Antibodies, High throughput screening Alex Himes Invenra Inc. QIMR...
BioCentury | Aug 3, 2015
Company News

Invenra, Oxford BioTherapeutics deal

...human mAbs against an undisclosed cancer target that Oxford identified using its OGAP discovery platform. Invenra...
...and will be responsible for development. Invenra is eligible to receive milestone payments and royalties. Invenra Inc....
Items per page:
1 - 8 of 8